Filspari and Rashes - a phase IV clinical study of FDA data

Summary:

Rashes is reported as a side effect among people who take Filspari (sparsentan), especially for people who are male, 30-39 old, have been taking the drug for < 1 month also take Farxiga, and have Iga nephropathy.

The phase IV clinical study analyzes which people have Rashes when taking Filspari. It is created by eHealthMe based on reports of 1,185 people who have side effects when taking Filspari from the FDA, and is updated regularly.

What is Filspari?

Filspari has active ingredients of sparsentan. eHealthMe is studying from 1,185 Filspari users. Check the latest studies of Filspari.

What is Rashes?

Rashes (redness) is found to be associated with 3,714 drugs and 6,214 conditions by eHealthMe. Check the latest studies of Rashes.

eHealthMe: drug outcomes in the real world

eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.

On Aug, 30, 2026

1,185 people reported to have side effects when taking Filspari.
Among them, 27 people (2.28%) have Rashes.

Among these 27 people:

How long have people been on Filspari when they have Rashes? *

What is the gender of people who have Rashes when taking Filspari? *

female: 40.74 %
male: 59.26 %

What is the age of people who have Rashes when taking Filspari? *

What are other drugs people take besides Filspari? *

What are other side effects people have besides Rashes? *

Itching: 7 people, 25.93%
Fatigue (feeling of tiredness): 6 people, 22.22%
Peripheral Swelling: 6 people, 22.22%
Hypotension (abnormally low blood pressure): 5 people, 18.52%
Dizziness: 4 people, 14.81%
Drowsiness: 3 people, 11.11%
Malaise (a feeling of general discomfort or uneasiness): 2 people, 7.41%
Abdominal Distension: 2 people, 7.41%
Back Pain: 2 people, 7.41%
Dehydration (dryness resulting from the removal of water): 2 people, 7.41%

What are the existing conditions these people have? *

Iga Nephropathy (kidney disease- condition prevents the kidneys from filtering waste): 22 people, 81.48%
Chronic Kidney Disease: 3 people, 11.11%
Haematuria (presence of blood in urine): 2 people, 7.41%

* Approximation only. Some reports may have incomplete information.

Do you take Filspari and have Rashes?

- Check whether Rashes is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Filspari:

Filspari (1,185 reports)

Rashes treatments and more:

Rashes (702,909 reports)

Browse all side effects of Filspari:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Rashes:

Rashes (3,715 drugs)

Browse all the conditions that are associated with Rashes:

Rashes (6,214 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on sparsentan (the active ingredients of Filspari) and Filspari (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.